Background-Quantification of the mitral valve area (MVA) is important to guide percutaneous mitral valve repair using the MitraClip system. However, little is known about how to best assess MVA in this specific situation. Methods and Results-Immediately before and after MitraClip implantation, comprehensive 3-dimensional (3D) transesophageal echocardiography data were acquired for MVA assessment by the pressure half-time method and by two 3D quantification methods (mitral valve quantification software and 3D quantification software). In addition, transmitral gradients by continuous-wave Doppler (dPmean CW ) were measured to indirectly assess MVA. Data are given as median (interquartile range). Thirty-three patients (39% women) with a median age of 77.1 years (12.4 years) were studied. Before intervention, the median MVAs by the pressure half-time method, mitral valve quantification software, and 3D quantification software were 4.4 cm 2 (2.0 cm 2 ), 4.7 cm 2 (2.4 cm 2 ), and 6.2 cm 2 (2.4 cm 2 ), respectively (P<0.001). After intervention, MVA was reduced to 1.9 cm 2 (0.7 cm 2 ), 2.1 cm 2 (1.1 cm 2 ), and 2.8 cm 2 (1.1 cm 2 ), respectively (P=0.001).
P ercutaneous mitral valve repair (MVR) using the MitraClip system has emerged as an alternative treatment option for patients with severe mitral regurgitation (MR) and a high risk for surgical MVR. 1 The Endovascular Valve Edge-to-Edge Repair Study (EVEREST II) trial has shown that percutaneous MVR is effective in reducing MR, improving clinical symptoms, and inducing reverse left ventricular remodeling. 2 As an intended side effect, percutaneous MVR using the MitraClip system leads to a reduction in the mitral valve orifice area (MVA). To prevent postprocedural mitral valve stenosis, the presence of an MVA <4 cm 2 was an exclusion criterion in the EVEREST trial. 3 
Clinical Perspective on p 1040
The assessment of MVA is crucial for the detection of a mitral stenosis and hence for decision making during percutaneous MVR. The 2009 European and American guidelines 4 recommend 2-dimensional (2D) planimetry and the use of the pressure half-time (PHT) method to assess MVA in native mitral stenosis, whereas the 2011 recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease do not specify how to assess MVA during percutaneous MVR. 5 Three-dimensional transesophageal echocardiography (3D TEE) has the potential to be the method of choice for MVA assessment. [6] [7] [8] Historically, however, invasive measurements were used for the validation of the PHT method for assessment of MVA in stenotic native valves. 9 The aim of this study was to compare different 2D and 3D echocardiographic methods of MVA assessment and invasive MVA calculations and to define which of these measurements best predicts an elevated transmitral gradient at discharge.
Methods

Patient Population
We included consecutive patients undergoing percutaneous MVR using the MitraClip system at the University Hospital Zurich, Zurich, Switzerland. Patients were selected for the procedure according to both the current guidelines on valvular heart disease and the previously published guidelines. 1, 10, 11 The clinical patient data were obtained by chart review. All patients gave written informed consent for inclusion in a prospective MitraClip registry (MitraSwiss registry). The protocol of the MitraSwiss registry was approved by the local institutional review board.
Echocardiography
TEE was performed using a Philips iE33 platform and an X7-2t real-time 3D TEE probe (Philips Medical Systems, Andover, MA). A 2D TTE was performed in all patients at the time of discharge. All measurements were performed according to the guidelines. 12 MR was graded mild (1+), moderate (2+), moderate to severe (3+), and severe (4+). 11 Mitral stenosis was defined by an MVA <2 cm 2 : mild, by 1.5 to 1.99 cm 2 ; moderate, by 1.0 to 1.49 cm 2 ; and severe, by <1 cm 2 . In addition, a mean transvalvular gradient ≥5 mm Hg was considered stenosed mitral valve. 4, 13 Immediately before the start of the procedure and after the last clip was placed, continuous-wave (CW) Doppler of mitral valve inflow was used for the assessment of the mean gradient across the mitral valve (dPmean CW ) and of MVA by PHT (MVA PHT ). 9 The beam of the CW Doppler was located in the center of the largest orifice after clipping to obtain a good-quality Doppler spectrum. In addition, full volumes (median frame rate=23 Hz [9 Hz]) or 3D zoom loops (median frame rate=12 Hz [3 Hz]) of the mitral valve were acquired ( Figure 1A and 1B) . Two different methods were used for 3D measurement of MVA: the mitral valve quantification software (MVA MVQ ; Figure 1C and 1D) and 3D quantification software (MVA 3DQ ; Figure 1E and 1F), both by Philips Medical Systems. MVQ is a specific software for 3D quantification of the mitral valve, and its use has previously been described. 14, 15 We used 28 landmarks to delineate the annulus and analyzed the mitral leaflets using ≤22 intersections per patient. The version 8.1 used in this study works identically to previous versions, with the addition of measuring MVA when the analysis is performed in diastole at the time of the peak valve opening (usually early diastole; Figure 1C and 1D). 3DQ is widely used for quantification in 3D but is not a specific mitral valve quantification software ( Figure 1E and 1F). The mitral valve can be displayed using 3 orthogonally orientated planes. So that MVA is not overestimated, the plane in which the measurement is performed is orientated perpendicularly to the valve leaflets 16, 17 After clipping, we adjusted the measurement plane separately for each orifice if necessary.
Invasive Measurements
In a subset of 14 patients, invasive measurements were performed immediately before MitraClip implantation and were repeated after deployment of the last clip as previously described. 10, 11 A Swan-Ganz catheter was used to measure mean pulmonary capillary wedge pressure, systolic pulmonary artery pressure, and pulmonary artery oxygen saturation. The left atrial pressure (LAP) was measured through the transseptal needle sheath (8F, at the beginning of procedure) and through the 24F MitraClip sheath after the procedure. A pigtail catheter was placed into the left ventricle for measurement of the left ventricular end-diastolic pressure, the transmitral gradients (dPmean INV ), and systemic artery oxygen saturation as previously described. 10, 11 The cardiac output and MVA were calculated using the Fick principle 18 and according to the Gorlin formula (MVA Gorlin ), respectively. 19
Statistical Analyses
Continuous data are expressed as median and interquartile range, and categorical data are given as number and percentage. Continuous data were compared using the Wilcoxon signed-rank test, and categorical data were analyzed using the χ 2 square or Fisher exact test, as appropriate. We used the Bland-Altman method and 1-factorial ANOVA, with the Kruskal-Wallis test for the comparison of the different MVA methods. We fitted univariable and multivariable linear regression models with dPmean CW at discharge as outcome variable. Three different models of multivariable analyses were considered by inclusion of clinically most meaningful factors of the univariable linear regression analysis (body surface area, the 3 different methods of measuring MVA, and dPmean CW ). An optimal cutoff for predicting an elevated transmitral gradient at discharge has been selected using the minimal P value approach. 20 The ability of postinterventional dPmean CW to predict elevated dPmean CW at discharge was quantified by receiver-operating characteristic analysis and calculation of the area under the curve, as well as sensitivity, specificity, and positive and negative predictive values for the determined cutoff value. A smoothed receiver-operating characteristic curve and 95% (bootstrap) confidence intervals for the area under the curve were obtained using a binormal model. 21 We used intraclass correlation coefficient to test for interobserver and intraobserver variability. A value of P<0.05 was considered statistically significant without adjustment for multiple testing. Statistical analyses were performed using R, version 2.15.2 (R Development Team, Vienna, Austria, 2011) and SPSS software (release 21.0, SPSS Inc, Chicago, IL). 
Results
Patient Population
Of the 58 patients who were screened and underwent percutaneous MVR, 33 were included in this study. The patients of this study partially overlap with the populations recently published. 10, 11 The main exclusion criteria were insufficient periprocedural 3D image quality (n=22) and missing dPmean CW at discharge (n=3). The median age of patients included was 77.1 years (12.4 years), and 39% were women (Table 1) .
Periprocedural Data
Blood pressure, heart rate, and systolic pulmonary artery pressure did not change significantly during the intervention (Figure 2 ). Nineteen patients (58%) received 2 clips, 9 patients (27%) received 1 clip, and 5 patients (15%) received ≥3 clips. The number of clips did not differ significantly between those developing stenosis and those without stenosis. The procedure resulted in significant reduction in MR, leaving 27 patients (75%) with only mild MR ( Figure 3 ). However, the procedure led to an MVA <2 cm 2 in 61% of patients if assessed by PHT, in 39% if measured by MVQ, and in 21% when quantified by 3DQ ( Figure 3 ). Accordingly, the dPmean CW increased from median (interquartile range) 1.0 mm Hg (1.0 mm Hg) to 3.0 mm Hg (3.0 mm Hg) postintervention (P<0.001), leaving 11 patients (33%) with a mean gradient between 5 and 10 mm Hg.
Comparison of MVA by the Different Methods
MVA assessed by 3DQ method resulted in larger absolute valve size compared with assessment by PHT or MVQ (P<0.001 preintervention and P=0.001 postintervention; Figure 4 ). However, the percentage of change measured by the 3 methods was almost identical (between 54% and 56%; Figure 2 ). Postintervention, the bias (in brackets: limits of agreements) according to the Bland-Altman analysis was smallest for comparison of MVA MVQ with MVA PHT (0.0 cm 2 [1.39]) and slightly greater for comparison MVA 3DQ with MVA MVQ (0.74 cm 2 [1.23] ) and MVA 3DQ with MVA PHT (0.74 cm 2 [1.49] ). Intraobserver variability by intraclass correlation coefficient for MVA by MVQ and 3DQ was 0.996 (0.990-0.998) and 0.998 (0.996-0.999), respectively. Interobserver variability by intraclass correlation coefficient for MVQ and 3DQ was 0.991 (0.978-0.997) and 0. 992 (0.980-0.997), respectively.
In a subset of 14 patients, MVA and transmitral gradients were assessed by invasive measurements in addition to all other parameters ( Table 2 ). In contrast to the entire study population, the mean LAP pre-and postclipping did not significantly change in the subgroup, whereas all other parameters performed comparably. Cardiac output increased significantly by 1.1 L/min (P=0.02); however, the MVA Gorlin and dPmean INV did not show significant periinterventional changes.
Predictors of Elevated Transmitral Gradients at Discharge
dPmean CW at discharge increased from 3.0 (3.0) to 4.0 (3.0) mm Hg (P<0.001) compared with postintervention, with 4 additional patients having elevated transmitral gradients. Univariable regression outputs for response to transmitral gradient at discharge are shown in Table 3 . Although heart rate and hemoglobin levels significantly changed from pre intervention to the time of discharge ( Figure 5 ), this did not significantly influence dPmean CW at discharge. In the 3 multivariable models testing the different MVA methods, all regression coefficients are in the expected direction with decreasing body surface area, decreasing MVA measurement, and increasing postinterventional dPmean CW predicting an increase in dPmean CW at discharge. The effect of immediate postinterventional dPmean CW was significant (P<0.001) in all 3 formulations, whereas there was only some evidence for the predictive value of body surface area and any of the 3 post-MVA measurements ( Table 4 ). In the receiver-operating characteristic analysis, the best cutoff value for predicting an elevated transmitral gradient at discharge was a postinterventional dPmean CW ≥5 mm Hg ( Figure 6 ).
Discussion
In this study on a prospective cohort of patients undergoing percutaneous MVR, we compared MVA immediately before and after intervention measured invasively and noninvasively by 3 different echocardiographic methods. Although the 3 echocardiographic methods measured similar relative reductions of MVA (between 53% and 56%), the absolute values varied considerably between these different techniques. In a multivariable linear regression analysis, the only consistent predictor of an elevated transmitral gradient at discharge was a postinterventional transmitral gradient by CW Doppler of ≥5 mm Hg. No preinterventional parameter was prognostic for the creation of a mitral stenosis, and invasive MVA measurements appeared invalid in this specific setting.
What Is the Best Method to Assess MVA During Percutaneous MVR?
For invasive MVA calculations and adequate hemodynamic measurements, the setting of percutaneous MVR is unique for the following reasons. (1) Left ventricular pressure, LAP, and volumes change completely within a few heartbeats after clip placement. 10 (2) The patient is intubated and ventilated, leading to a reduction in left ventricular afterload, supranormal oxygen saturation in the pulmonary artery, and thus overestimation of left ventricular stroke volumes calculated using the Fick principle. 11, 18 (3) The procedure is associated with the creation of an atrial septal defect, further influencing stroke volume calculations because of left-to-right shunt. (4) MR is not accounted for in the Gorlin formula and leads to overestimation of the degree of mitral stenosis. 22 (5) Continuous measurement of LAP is not possible by the current generation of devices. Postinterventional LAP measurements can be performed only once the steering catheter is retrieved and hence after the release of a clip. These circumstances explain why invasive measurements of transmitral gradients and MVA using the Gorlin formula have led to erroneous measurements in our study and, because of the technical limitation, cannot be used for decision making.
Assessment of MVA by echocardiography has a long-standing tradition and has been validated in various settings. In our study, MVA PHT before and after intervention was similar to that measured by MVQ method, but both measurements appeared to underestimate the true orifice. By the PHT method, 20 patients (61%) had a postinterventional MVA <2 cm 2 , whereas only 11 patients (33%) had elevated postinterventional transmitral gradients. The PHT method is validated in stenotic mitral valves and in patients with combinations of mitral stenosis and MR and is relatively flow independent. 9 However, it is largely dependent on the left ventricular compliance, and its accuracy is lower in subjects with relevant diastolic dysfunction. In addition, it should not be used immediately after creation of an atrial septal defect by transseptal puncture because this overestimates the valve area. 4 Furthermore, measuring MVA by PHT has been found to be a source of error immediately after mitral valvuloplasty and surgical MVR because of the acute changes in loading conditions and valve geometry. 23, 24 All our patients had a combination of these conditions that limit the accuracy of the PHT method, which may explain the overall underestimation of MVA by PHT. The overestimation of MVA because of the atrial septal defect might be less relevant as long as the guidance catheter is in place. The underestimation of MVA MVQ is technically driven because the software limits the tracing of the opening area near the commissures. Although MVA MVQ independently predicted mitral stenosis at discharge and thus might be closest to the true MVA, the technique cannot be used for intraprocedural decision making because advanced operator skills in 3D reconstruction are needed and the reconstruction is rather time intensive. Compared with MVA PHT and MVA MVQ , MVA 3DQ was larger both before and after intervention. Our results for MVA 3DQ are similar to those recently published in the only other study that used the same technique for MVA assessment. 16 The 3DQ method tends to overestimate MVA if the orifices resulting from clipping are not calculated separately (Figure 7 ). Although we followed this rule for measurement, we cannot exclude that slight overestimation of the MVA occurred because of relatively low spatial resolution of 3D data sets.
The degree of change during the procedure was similar in all 3 methods, representing a good consistency in measurements. However, in the absence of a reference method for assessment of the MVA during and after percutaneous MVR and on the basis of our results, we cannot determine the best method to directly assess MVA in this specific setting.
CW Doppler Is an Alternative to MVA Measurements
An indirect way of assessing MVA or the risk of stenosis is measuring the transvalvular gradient by CW Doppler. Values of ≥5 mm Hg are associated with a moderate mitral stenosis in native valves, 4 and CW Doppler measurements are valid in both single-and double-orifice area mitral valves. 25 Our results of postinterventional dPmean CW were comparable to those of the EVEREST population and 2 European studies. [26] [27] [28] One of the limitations of CW Doppler measurements is its dependency on hemodynamic parameters such as hemoglobin levels and heart rate. 4 In our study, the dPmean CW measurements at discharge were higher than measurements postprocedurally, but according to the univariate analysis, the CW Doppler values at discharge were not influenced by the increase in heart rate and the decrease in hemoglobin levels.
Can CW Doppler be used instead of direct peri-interventional MVA assessment to prevent mitral stenosis during percutaneous MVR? This question cannot be answered by our study. However, the postinterventional dPmean CW was consistently the best predictor of an elevated transmitral gradient at discharge, with a positive predictive value of 100% at a cutoff level ≥5 mm Hg. We also noted that factors influencing transmitral gradients by CW Doppler undergo significant changes between the end of the procedure and discharge: Hemoglobin decreases and the heart rate increases. Considering these changes, it comes as no surprise that the transmitral gradient at discharge was higher compared with that immediately after intervention. In light of these results, it is, however, noteworthy that the predictor of an elevated transmitral gradient at discharge was not lower than 5 mm Hg.
Currently, there is no gold standard method to measure MVA (and hence mitral stenosis) during MitraClip procedure. Furthermore, we do not know whether a transmitral gradient ≥5 mm Hg truly represents mitral stenosis and whether the creation of a mitral stenosis has a prognostic impact in this population. To the best of our knowledge, a peri-interventional transmitral gradient ≥5 mm Hg should at least be of concern.
Limitations We have to acknowledge a relative small sample size and a large number of patients excluded because of insufficient 3D TEE image quality. Although the 3D images were sufficient for procedure guidance, they were of insufficient quality for the use of the 3D reconstruction software in the excluded patients.
We used the predischarge transmitral gradient as an end point of the study instead of a measured MVA because 3D TTE has insufficient image resolution for the assessment of MVA in most postinterventional patients. We did not use 2D TTE measurements because they tend to overestimate MVA, 16, 17 and performing another 3D TEE before discharge was not justifiable. Also, it should be expected that with normalization of the hemoglobin level, the transmitral gradients should slightly decrease over time. However, in the study of Herrmann et al, 27 the transmitral gradients did not change significantly within 24 months of follow-up.
The lower frame rate of 3D zoom acquisitions used in patients with atrial fibrillation may have limited the accuracy of this study. As the frame rate lowers, the chances that the frame with the largest valve opening is missed increase, leading to an underestimation of MVA. This could have influenced the comparison with the PHT method but not the correlation between MVQ and 3DQ because they are based on the same data set.
Conclusion
In the absence of a reference method for assessment of MVA changes during percutaneous MVR and on the basis of our results, we cannot determine the best method to directly assess MVA in this specific setting. However, a postinterventional transmitral gradient by CW Doppler echocardiography of ≥5 mm Hg consistently predicted elevated transmitral gradients at discharge. CW Doppler measurements are quick, are feasible in all patients, and should be used for indirect peri-interventional assessment of MVA. 
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